VRC07-523LS (VRC-HIVMAB075-00-AB)

VRC07-523LS · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRC07-523LS (VRC-HIVMAB075-00-AB), covering 2019-07-11 to 2019-07-11. Get the full timeline:

Most recent: Clinical Trial Update: VRC 605: Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy Adults [Phase 1]

See pricing